ŚCO Kielce
Published on ŚCO Kielce (https://onkol.kielce.pl)

Strona główna > Nauka

Polski

The influence of composition of coal briquettes on changes in volume of the heated coal charge [1]

Title: The influence of composition of coal briquettes on changes in volume of the heated coal charge
Author(s): Zubkova, V.; Strojwas, A.; Strojanowska, M.; et al.
Source: Fuel Processing Technology Volume: 128 Pages: 265-275 Published: 2014
Times Cited: 1
DOI: 10.1016/j.fuproc.2014.07.022

Polski
  • Czytaj dalej wpis The influence of composition of coal briquettes on changes in volume of the heated coal charge [1]

The International Multiple Myeloma Research (IMMEnSE) Consortium: Genetics of Multiple Myeloma Risk and Prognosis [2]

Title: The International Multiple Myeloma Research (IMMEnSE) Consortium: Genetics of Multiple Myeloma Risk and Prognosis
Author(s): Canzian, Federico; Beider, Katia; Buda, Gabriele; et al.
Source: Blood Volume: 124 Issue: 21 Published: 2014
Times Cited: 0

Polski
  • Czytaj dalej wpis The International Multiple Myeloma Research (IMMEnSE) Consortium: Genetics of Multiple Myeloma Risk and Prognosis [2]

The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan [3]

Title: The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan
Author(s): Trybek, Tomasz; Kowalska, Aldona; Lesiak, Jacek; et al.
Source: Nuclear medicine review. Central & Eastern Europe Volume: 17 Issue: 2 Pages: 87-93 Published: 2014

Polski
  • Czytaj dalej wpis The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan [3]

Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium [4]

Title: Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium
Author(s): Sainz, Juan; Belen Lupianezs, Carmen; Campa, Daniele; et al.
Source: Blood Volume: 124 Issue: 21 Published: 2014
Times Cited: 0

Polski
  • Czytaj dalej wpis Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium [4]

X-ray Diffraction and Elemental Analysis of Medical and Environmental Samples [5]

Title: X-ray Diffraction and Elemental Analysis of Medical and Environmental Samples
Author(s): Bielecka, K.; Kurtek, W.; Banas, D.; et al.
Source: Acta Physica Polonica A Volume: 125 Issue: 4 Pages: 911-918 Published: 2014
Times Cited: 2

Polski
  • Czytaj dalej wpis X-ray Diffraction and Elemental Analysis of Medical and Environmental Samples [5]

X-Ray Fluorescence Techniques in Medical Applications: Reference Values of Elements in Human Serum, Urine and Hair [6]

Title: X-Ray Fluorescence Techniques in Medical Applications: Reference Values of Elements in Human Serum, Urine and Hair
Author(s): Majewska, U.; Banas, D.; Braziewicz, J.; et al.
Source: Acta Physica Polonica A Volume: 125 Issue: 4 Pages: 864-868 Published: 2014
Times Cited: 3

Polski
  • Czytaj dalej wpis X-Ray Fluorescence Techniques in Medical Applications: Reference Values of Elements in Human Serum, Urine and Hair [6]

ACTIVE TRANSPORT OF RB PROTEIN FROM THE NUCLEUS TO THE CYTOPLASM AS ONE OF THE DEVELOPMENT MECHANISMS OF HER2-POSITIVE BREAST CANCER [7]

Title: ACTIVE TRANSPORT OF RB PROTEIN FROM THE NUCLEUS TO THE CYTOPLASM AS ONE OF THE DEVELOPMENT MECHANISMS OF HER2-POSITIVE BREAST CANCER
Author(s): Kowalik, Artur; Kopczynski, Janusz; Wypiorkiewicz, Elzbieta; et al.
Source: Polish Journal of Pathology Volume: 64 Issue: 1 Pages: 9-14 Published: 2013
Times Cited: 2
DOI: 10.5114/pjp.2013.34597

Polski
  • Czytaj dalej wpis ACTIVE TRANSPORT OF RB PROTEIN FROM THE NUCLEUS TO THE CYTOPLASM AS ONE OF THE DEVELOPMENT MECHANISMS OF HER2-POSITIVE BREAST CANCER [7]

ADVERSE EVENT PROFILE BY AGE FOR VINTAFOLIDE plus PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) VS PLD ALONE IN PLATINUM-RESISTANT OVARIAN CANCER [8]

Title: ADVERSE EVENT PROFILE BY AGE FOR VINTAFOLIDE plus PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) VS PLD ALONE IN PLATINUM-RESISTANT OVARIAN CANCER
Author(s): Coleman, R.; Bidzinski, M.; Kutarska, E.; et al.
Source: International Journal of Gynecological Cancer Volume: 23 Issue: 8 Published: 2013
Times Cited: 0

Polski
  • Czytaj dalej wpis ADVERSE EVENT PROFILE BY AGE FOR VINTAFOLIDE plus PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) VS PLD ALONE IN PLATINUM-RESISTANT OVARIAN CANCER [8]

Adverse event profile by folate receptor status for vintafolide plus pegylated liposomal doxorubicin (PLD) vs PLD alone in platinum-resistant ovarian cancer [9]

Title: Adverse event profile by folate receptor status for vintafolide plus pegylated liposomal doxorubicin (PLD) vs PLD alone in platinum-resistant ovarian cancer
Author(s): Herzog, T.; Kutarska, E.; Bidzinski, M.; et al.
Source: European Journal of Cancer Volume: 49 Pages: S731 Published: 2013
Times Cited: 0

Polski
  • Czytaj dalej wpis Adverse event profile by folate receptor status for vintafolide plus pegylated liposomal doxorubicin (PLD) vs PLD alone in platinum-resistant ovarian cancer [9]

Adverse event profile by therapy cycle for vintafolide plus pegylated liposomal doxorubicin (PLD) versus PLD alone in platinum-resistant ovarian cancer [10]

Title: Adverse event profile by therapy cycle for vintafolide plus pegylated liposomal doxorubicin (PLD) versus PLD alone in platinum-resistant ovarian cancer
Author(s): Symanowski, James Thomas; Kutarska, Elzbieta; Bidzinski, Mariusz; et al.
Source: Journal of Clinical Oncology Volume: 31 Issue: 15 Published: 2013
Times Cited: 0

Polski
  • Czytaj dalej wpis Adverse event profile by therapy cycle for vintafolide plus pegylated liposomal doxorubicin (PLD) versus PLD alone in platinum-resistant ovarian cancer [10]

Strony

  • « pierwsza [11]
  • ‹ poprzednia [12]
  • …
  • 6 [13]
  • 7 [14]
  • 8 [15]
  • 9 [12]
  • 10
  • 11 [16]
  • 12 [17]
  • 13 [18]
  • 14 [19]
  • …
  • następna › [16]
  • ostatnia » [20]

Source URL:https://onkol.kielce.pl/pl/sekcja/nauka?mini=2022-10&page=9

Links
[1] https://onkol.kielce.pl/pl/nauka/influence-composition-coal-briquettes-changes-volume-heated-coal-charge [2] https://onkol.kielce.pl/pl/nauka/international-multiple-myeloma-research-immense-consortium-genetics-multiple-myeloma-risk-and [3] https://onkol.kielce.pl/pl/nauka/role-18f-fluorodeoxyglucose-positron-emission-tomography-patients-suspected-recurrence-or [4] https://onkol.kielce.pl/pl/nauka/type-2-diabetes-related-variants-influence-risk-developing-multiple-myeloma-results-immense [5] https://onkol.kielce.pl/pl/nauka/x-ray-diffraction-and-elemental-analysis-medical-and-environmental-samples [6] https://onkol.kielce.pl/pl/nauka/x-ray-fluorescence-techniques-medical-applications-reference-values-elements-human-serum-urine [7] https://onkol.kielce.pl/pl/nauka/active-transport-rb-protein-nucleus-cytoplasm-one-development-mechanisms-her2-positive-breast [8] https://onkol.kielce.pl/pl/nauka/adverse-event-profile-age-vintafolide-plus-pegylated-liposomal-doxorubicin-pld-vs-pld-alone [9] https://onkol.kielce.pl/pl/nauka/adverse-event-profile-folate-receptor-status-vintafolide-plus-pegylated-liposomal-doxorubicin [10] https://onkol.kielce.pl/pl/nauka/adverse-event-profile-therapy-cycle-vintafolide-plus-pegylated-liposomal-doxorubicin-pld [11] https://onkol.kielce.pl/pl/sekcja/nauka?mini=2022-10 [12] https://onkol.kielce.pl/pl/sekcja/nauka?page=8&mini=2022-10 [13] https://onkol.kielce.pl/pl/sekcja/nauka?page=5&mini=2022-10 [14] https://onkol.kielce.pl/pl/sekcja/nauka?page=6&mini=2022-10 [15] https://onkol.kielce.pl/pl/sekcja/nauka?page=7&mini=2022-10 [16] https://onkol.kielce.pl/pl/sekcja/nauka?page=10&mini=2022-10 [17] https://onkol.kielce.pl/pl/sekcja/nauka?page=11&mini=2022-10 [18] https://onkol.kielce.pl/pl/sekcja/nauka?page=12&mini=2022-10 [19] https://onkol.kielce.pl/pl/sekcja/nauka?page=13&mini=2022-10 [20] https://onkol.kielce.pl/pl/sekcja/nauka?page=19&mini=2022-10